Form 4 Filing: Shah Rajeev M. Acquires (Grant) shares of $TYRA
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Shah Rajeev M., holds the title of Director at Tyra Biosciences, Inc..
On 2026-05-28, the insider transacted 13,160 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
**Transaction:** grant of 13,160 shares by Shah Rajeev M. (Director). **Strategic Implications (Investor Edge):** This grant is a routine compensation event and provides no actionable signal about the insider's view of the stock's value. Investors should not interpret this as bullish or bearish conviction. **Key Takeaways:** - The transaction is a grant, not an open market buy, so it lacks the conviction signal of a purchase. - The insider's total direct ownership is relatively small, indicating limited personal financial exposure. - No price or value was reported, typical for grants, making it impossible to assess valuation sentiment.
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.